Corrigendum to "In vitro susceptibility to the pro-apoptotic effects of TIMP-3 gene delivery translates to greater in vivo efficacy versus gene delivery for TIMPs-1 or -2" [Lung Cancer 53 (3) (September 2006) 273-284].
Department of Thoracic Medicine and Lung Research Laboratory, Royal Adelaide Hospital and Hanson Institute Adelaide, South Australia 5000, Australia.
Katherine M
KM
Finan
Department of Thoracic Medicine and Lung Research Laboratory, Royal Adelaide Hospital and Hanson Institute Adelaide, South Australia 5000, Australia; Department of Haematology, Women's and Children's Hospital, Adelaide, South Australia 5000, Australia; University of Adelaide, Adelaide, South Australia 5000, Australia.
Greg
G
Hodge
Department of Thoracic Medicine and Lung Research Laboratory, Royal Adelaide Hospital and Hanson Institute Adelaide, South Australia 5000, Australia.
Ann M
AM
Reynolds
Department of Thoracic Medicine and Lung Research Laboratory, Royal Adelaide Hospital and Hanson Institute Adelaide, South Australia 5000, Australia.
Sandra
S
Hodge
Department of Thoracic Medicine and Lung Research Laboratory, Royal Adelaide Hospital and Hanson Institute Adelaide, South Australia 5000, Australia; University of Adelaide, Adelaide, South Australia 5000, Australia.
Mark D
MD
Holmes
University of Glasgow, Glasgow, UK.
Andrew H
AH
Baker
Department of Thoracic Medicine and Lung Research Laboratory, Royal Adelaide Hospital and Hanson Institute Adelaide, South Australia 5000, Australia; University of Adelaide, Adelaide, South Australia 5000, Australia. Electronic address: paul.reynolds@adelaide.edu.au.
Paul N
PN
Reynolds